-
Something wrong with this record ?
In vivo monitoring of rat macrophages labeled with poly(l-lysine)-iron oxide nanoparticles
M. Babič, M. Schmiedtová, R. Poledne, V. Herynek, D. Horák,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
25283523
DOI
10.1002/jbm.b.33292
Knihovny.cz E-resources
- MeSH
- Cell Tracking methods MeSH
- Contrast Media * chemistry pharmacology MeSH
- Rats MeSH
- Magnetic Resonance Imaging methods MeSH
- Macrophages radiography MeSH
- Nanoparticles chemistry MeSH
- Polylysine * chemistry pharmacology MeSH
- Particle Size MeSH
- Ferric Compounds * chemistry pharmacology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Coprecipitation of FeCl2 and FeCl3 with aqueous ammonia was used to prepare iron oxide nanoparticles dispersible in aqueous medium. Oxidation of the particles with sodium hypochlorite then yielded maghemite (γ-Fe2 O3 ) nanoparticles which were coated with two types of coating -d-mannose or poly(l-lysine) (PLL) as confirmed by FTIR analysis. The particles were <10 nm according to transmission electron microscopy. Their hydrodynamic particle size was ∼180 nm (by dynamic light scattering). The d-mannose-, PLL-coated, and neat γ-Fe2 O3 particles as well as commercial Resovist® were used to label rat macrophages. The viability and contrast properties of labeled macrophages were compared. PLL-coated γ-Fe2 O3 nanoparticles were found optimal. The labeled macrophages were injected to rats monitored in vivo by magnetic resonance imaging up to 48 h. Transport of macrophages labeled with PLL-γ-Fe2 O3 nanoparticles in rats was confirmed. Tracking of macrophages using the developed particles can be used for monitoring of inflammations and cell migration in cell therapy.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16021051
- 003
- CZ-PrNML
- 005
- 20160801101552.0
- 007
- ta
- 008
- 160722s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jbm.b.33292 $2 doi
- 024 7_
- $a 10.1002/jbm.b.33292 $2 doi
- 035 __
- $a (PubMed)25283523
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Babič, Michal $u Institute of Macromolecular Chemistry, Department of Polymer Particles, Academy of Sciences of the Czech Republic, 162 06, Prague 6, Czech Republic.
- 245 10
- $a In vivo monitoring of rat macrophages labeled with poly(l-lysine)-iron oxide nanoparticles / $c M. Babič, M. Schmiedtová, R. Poledne, V. Herynek, D. Horák,
- 520 9_
- $a Coprecipitation of FeCl2 and FeCl3 with aqueous ammonia was used to prepare iron oxide nanoparticles dispersible in aqueous medium. Oxidation of the particles with sodium hypochlorite then yielded maghemite (γ-Fe2 O3 ) nanoparticles which were coated with two types of coating -d-mannose or poly(l-lysine) (PLL) as confirmed by FTIR analysis. The particles were <10 nm according to transmission electron microscopy. Their hydrodynamic particle size was ∼180 nm (by dynamic light scattering). The d-mannose-, PLL-coated, and neat γ-Fe2 O3 particles as well as commercial Resovist® were used to label rat macrophages. The viability and contrast properties of labeled macrophages were compared. PLL-coated γ-Fe2 O3 nanoparticles were found optimal. The labeled macrophages were injected to rats monitored in vivo by magnetic resonance imaging up to 48 h. Transport of macrophages labeled with PLL-γ-Fe2 O3 nanoparticles in rats was confirmed. Tracking of macrophages using the developed particles can be used for monitoring of inflammations and cell migration in cell therapy.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a buněčný tracking $x metody $7 D058948
- 650 12
- $a kontrastní látky $x chemie $x farmakologie $7 D003287
- 650 12
- $a železité sloučeniny $x chemie $x farmakologie $7 D005290
- 650 _2
- $a makrofágy $x radiografie $7 D008264
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nanočástice $x chemie $7 D053758
- 650 _2
- $a velikost částic $7 D010316
- 650 12
- $a polylysin $x chemie $x farmakologie $7 D011107
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Schmiedtová, Martina $u Institute for Clinical and Experimental Medicine, Laboratory for Atherosclerosis Research, 140 21, Prague 4, Czech Republic.
- 700 1_
- $a Poledne, Rudolf $u Institute for Clinical and Experimental Medicine, Laboratory for Atherosclerosis Research, 140 21, Prague 4, Czech Republic.
- 700 1_
- $a Herynek, Vít $u Institute for Clinical and Experimental Medicine, Laboratory for Atherosclerosis Research, 140 21, Prague 4, Czech Republic. Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská, 1083, Czech Republic.
- 700 1_
- $a Horák, Daniel $u Institute of Macromolecular Chemistry, Department of Polymer Particles, Academy of Sciences of the Czech Republic, 162 06, Prague 6, Czech Republic.
- 773 0_
- $w MED00007497 $t Journal of biomedical materials research. Part B, Applied biomaterials. Applied biomaterials $x 1552-4981 $g Roč. 103, č. 6 (2015), s. 1141-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25283523 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160801101819 $b ABA008
- 999 __
- $a ok $b bmc $g 1155721 $s 945579
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 103 $c 6 $d 1141-8 $e 20141006 $i 1552-4981 $m Journal of biomedical materials research. Part B, Applied biomaterials $n J Biomed Mater Res $x MED00007497 $o Applied biomaterials
- LZP __
- $a Pubmed-20160722